Myungin Haloperidol Tablet 20 mg

Adult dose

○ Adults and children (14 years and older) Schizophrenia, manic episodes associated with bipolar I disorder, symptoms of psychotic disorders, Tourette syndrome (Gilles de la Tourette's syndrome): Administer an initial dose of haloperidol 1-15㎎ per day orally in 2-3 divided doses (up to 100㎎ may be administered in severe cases). Once a therapeutic response is achieved, gradually adjust the dose downward to the minimum effective maintenance dose. Adjust the dose as appropriate according to age and symptoms. For older adults and debilitated patients, administer an initial dose of haloperidol 1-6mg per day orally in 2-3 divided doses.

Child dose

For children aged 14 years and older, administer Haloperidol in an initial dose of 1-15 mg orally, divided into 2-3 doses per day, similar to adults. The dosage for elderly and frail patients should be adjusted separately.

This drug may increase mortality in elderly dementia patients, so it must be used with caution. There may be an increased risk of cerebrovascular diseases; therefore, patients with stroke risk factors should be carefully monitored. There is also a risk of venous thromboembolism, so thromboembolism risk factors should be checked and preventive measures taken before and during the use of this drug. It should not be administered to patients with hypersensitivity to this drug, those in coma, with alcohol dependence, or with severe heart failure. Patients with Parkinson's disease, Lewy body dementia, pregnant or breastfeeding women, and those taking medications that prolong the QTc interval should also not use this drug. Caution is advised for patients with impaired liver or kidney function or with a history of cardiovascular disease, convulsive disorders, or thyroid dysfunction. This drug can cause cardiovascular adverse reactions such as abnormal electrocardiograms, blood pressure changes, and arrhythmias, so careful observation is necessary. Serious neurological side effects such as neuroleptic malignant syndrome, extrapyramidal symptoms, and akathisia may occur, so symptoms should be closely monitored. Regular examinations are required as various side effects, including liver dysfunction, visual disturbances, hypersensitivity reactions, blood abnormalities, gastrointestinal issues, and endocrine abnormalities, may arise. This drug may cause drowsiness and decreased attention, so caution is needed during driving or machinery operation, and sudden discontinuation may cause withdrawal symptoms, hence it should be tapered gradually. Combining with other central nervous system depressants or certain medications may result in interactions, and it is essential to consult with healthcare professionals for medication adjustments. Pregnant women, those who may become pregnant, and breastfeeding women should not use this drug, and breastfeeding should be stopped during its use. In cases of overdose, severe side effects may occur, and immediate medical attention is necessary. Elderly patients, in particular, may exhibit symptoms such as hypotension, movement disorders, and cognitive decline, requiring dose adjustments and careful observation.

Increased mortality, increased risk of cerebrovascular disease, venous thromboembolism, abnormal electrocardiogram, hypotension, hypertension, tachycardia, ventricular tachycardia, thromboembolism, motor paralysis, severe muscle rigidity, dysphagia, diaphoresis, fever, increased white blood cells, elevated serum CPK, myoglobinuria, decreased kidney function, high fever, consciousness disorders, dyspnea, circulatory collapse, dehydration symptoms, acute renal failure, acute dystonia, opisthotonos, trismus, parkinsonian rigidity, tremors, immobility, inability to sit, dystonic movement disorder, hepatitis, jaundice, liver dysfunction, retinitis, cataract, accommodation disorder of the eye, blurred vision, corneal opacity, lens opacity, corneal pigmentation, edema, erythema, urticaria, exfoliative dermatitis, photosensitivity, anaphylactic reaction, anemia, leukocytosis, leukopenia, erythropenia, agranulocytosis, loss of appetite, nausea, vomiting, constipation, diarrhea, intestinal paralysis, paralytic ileus, hyperprolactinemia, gynecomastia in women, galactorrhea, menstrual irregularities, changes in libido, hyperglycemia, hypoglycemia, weight gain, weight loss, hyponatremia, hypopituitarism, syndrome of inappropriate antidiuretic hormone secretion, bronchospasm, laryngospasm, dyspnea, insomnia, anxiety, drowsiness, dizziness, headache, cephalalgia, anxiety, depression, hallucinations, agitation, thirst, nasal congestion, fatigue, urinary retention, fever, sweating, flushing, hypothermia

This drug is sensitive to light and should be stored in a tightly closed container that blocks light. This will help maintain the effectiveness of the drug's components.

Appearance

Brownish round tablet.

Package unit

500 tablets/bottle